On March 11, The 19th, an independent, nonprofit newsroom reporting on gender, politics and policy, hosted a virtual summit about healthcare equity in the context of the nation’s ongoing fight to defeat COVID-19. The event featured important and unique perspectives from the women directing the Biden-Harris administration’s pandemic response as well as other public health, health policy and healthcare industry leaders.
We have reached another pivotal moment in the fight against COVID-19: the Food and Drug Administration (FDA) has authorized Johnson & Johnson’s COVID-19 vaccine candidate for emergency use. With demand for vaccines currently outpacing supply, the addition of a third candidate is welcome news for Americans. Most importantly, a one-dose option that only requires refrigeration will provide greater flexibility in delivering vaccines to more individuals, including those in underserved and rural areas, with the ability to scale up production exponentially as we move into the spring and summer months.